Cover Image
市場調查報告書

神經刺激設備市場分析:各產品(深層腦部刺激器,胃電刺激設備,脊髓刺激設備,薦骨神經刺激器,迷走神經刺激設備),各用途,及市場區隔預測

Neurostimulation Devices Market Analysis By Product (Deep Brain Stimulators, Gastric Electric Stimulators, Spinal Cord Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators), By Application, And Segment Forecasts To 2024

出版商 Grand View Research, Inc. 商品編碼 374574
出版日期 內容資訊 英文 78 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經刺激設備市場分析:各產品(深層腦部刺激器,胃電刺激設備,脊髓刺激設備,薦骨神經刺激器,迷走神經刺激設備),各用途,及市場區隔預測 Neurostimulation Devices Market Analysis By Product (Deep Brain Stimulators, Gastric Electric Stimulators, Spinal Cord Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators), By Application, And Segment Forecasts To 2024
出版日期: 2016年09月12日 內容資訊: 英文 78 Pages
簡介

本報告提供全球神經刺激設備市場相關調查,市場概要和今後預測,彙整各市場區隔及地區別趨勢,及加入此市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場變動,趨勢,及範圍

  • 市場區隔和範圍
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 市場趨勢
  • 優先的主要的機會
  • 產業分析:波特五力分析
  • PESTEL分析
  • 市場佔有率分析

第4章 市場類別1:各產品預測與趨勢分析

  • 神經刺激設備市場:各產品趨勢分析
  • 脊髓刺激設備
  • 深層腦部刺激器
  • 薦骨神經刺激器
  • 迷走神經刺激設備
  • 胃電刺激設備

第5章 市場類別2:各用途預測與趨勢分析

  • 神經刺激設備市場:各用途趨勢分析
  • 疼痛管理
  • 癲癇
  • 原發性顫抖症
  • 尿失禁及大便失禁
  • 憂鬱
  • 肌張力不全症
  • 胃輕癱
  • 帕金森氏症
  • 其他

第6章 市場類別3:各地區預測及趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • 企業簡介
目錄
Product Code: 978-1-68038-066-8

The neurostimulation devices market is expected to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. The neurostimulation devices market is anticipated to witness a significant growth during the study period from 2016 to 2024. This growth is majorly attributed to high prevalence of chronic diseases, including migraine and epilepsy. Increasing adoption of unhealthy lifestyle, diet, and growth in aging population is resulting in a growing incidence of the chronic disease in individuals. However, adverse effects and risks associated with neurostimulation devices and presence of stringent device approval regulations are expected to hamper the growth.

Apart from the above mentioned factors, increasing incidence of road traffic accidents (RTAs) is also an additional factor propagating growth. Hence, the neurostimulation devices market holds enormous growth prospects and as a result manufacturers are participating in precise R&D exercises to develop new products empowered by advance technology. Some of the technological advancements such as the following are expected to serve as drivers:

Minimally invasive transdermal neuromodulation technology by Neurowave Medical Technologies

MRI safety incorporated devices by Medtronic Inc.

Further Key Findings from the Study Suggest:

North America is estimated to dominate the global neurostimulation devices market. The growing demand for neurostimulation devices as an add-on therapy, presence of high patient disposable incomes &patient awareness levels coupled with sophisticated healthcare infrastructure and high prevalence of target diseases, such as epilepsy, Parkinson's disease, incontinence, etc., are expected to facilitate growth in near future

Asia Pacific is the fastest growing region in the neurostimulation devices. The high growth rate is explained by the following drivers:

Economic developments in emerging areas, such as India and China

Rising healthcare expenditures

Presence of unmet medical needs and untapped markets coupled with increasing patient disposable incomes

Changing lifestyle of the people resulting in various lifestyle-related diseases, for example, low-back pain resulting from long working hours.

Increasing RTAs, for example, nerve injuries (paralysis) due to RTA, which require neurostimulation postoperatively

The immense growth opportunities available in the Asia Pacific region have attracted manufacturers to enter these areas, for example, Medtronic aims at generating 20% of its revenue from emerging economies in the next 5 years, commencing from 2011

Spinal cord stimulation devices dominated the market in 2015 with highest share of over 54.0%. These devices were the prime neurostimulation devices to be commercialized, thus, hold a competitive edge over the rest of the devices in terms of share. The cost-effectiveness provided by these devices in terms of quality-adjusted life years will also drive the growth

Pain management dominated the overall market in terms of revenue share at over 65.0% in 2015. High global prevalence of chronic pain disorders and the growing adoption rates of neurostimulation devices for pain management were the major drivers recognized as contributors to the growth

The industry involves several global as well as local players. Some of the key players are Medtronic; St. Jude Medical; Boston Scientific Corporation; Cyberonics, Inc.; and Nevro Corporation. New and innovative product development using latest technology is expected to be a universal strategy followed by the players

For instance, in June, 2015, according to new data presented by Boston Scientific Corporation, the company's spinal cord stimulator system, also known as Precision Spectra, claimed that the system provided better pain relief than its previous generation of Precision Plus SCS systems

Table of Content

Chapter 1: Research Methodology

Chapter 2: Executive Summary

Chapter 3: Market Variables, Trends & Scope

  • 3.1. Market Segmentation & Scope
    • 3.1.1. Market Driver Analysis
      • 3.1.1.1. Growing geriatric population base
      • 3.1.1.2. Introduction of technological advancements
      • 3.1.1.3. Growing demand for neurostimulation devices as an add on therapy
      • 3.1.1.4. Increasing global prevalence of chronic diseases such as migraine and epilepsy and the presence of high unmet medical needs in these disease segments
      • 3.1.1.5. Growing prevalence of lifestyle induced disorders such as obesity and depression
      • 3.1.1.6. External funding for executing research and development exercises
      • 3.1.1.7. Growing demand for minimally invasive surgeries
    • 3.1.2. Market restraints
      • 3.1.2.1. Adverse effects and risks associated with neurostimulation devices
      • 3.1.2.2. Presence of stringent device approval regulations
      • 3.1.2.3. Availability of external substitutes or alternative therapeutic procedures
  • 3.2. Neurostimulation Devices-Market Dynamics
  • 3.3. Key Opportunities Prioritized
  • 3.4. Industry Analysis-Porter's
  • 3.5. Neurostimulation Devices-PESTLE Analysis
  • 3.6. Neurostimulation Devices Market: Company Market Share Analysis, 2015

Chapter 4: Market Categorization 1: Product Estimates & Trend Analysis

  • 4.1. Neurostimulation Devices Market: Product Movement Analysis
  • 4.2. Spinal Cord Stimulators Market
    • 4.2.1. Spinal cord stimulators market, 2013-2024(USD Million)
    • 4.2.2. Spinal cord stimulators market, 2013-2024('000 Units)
  • 4.3. Deep Brain Stimulators Market
    • 4.3.1. Deep brain stimulators market, 2013-2024(USD Million)
    • 4.3.2. Deep brain stimulators market, 2013-2024('000 Units)
  • 4.4. Sacral Nerve Stimulators Market
    • 4.4.1. Sacral nerve stimulators market, 2013-2024(USD Million)
    • 4.4.2. Sacral nerve stimulators market, 2013-2024('000 Units)
  • 4.5. Vagus Nerve Stimulators Market
    • 4.5.1. Vagus nerve stimulators market, 2013-2024(USD Million)
    • 4.5.2. Vagus nerve stimulators market, 2013-2024('000 Units)
  • 4.6. Gastric Electric Stimulators Market
    • 4.6.1. Gastric electric stimulators market, 2013-2024(USD Million)
    • 4.6.2. Gastric electric stimulators market, 2013-2024('000 Units)

Chapter 5: Market Categorization 2: Application Estimates & Trend Analysis

  • 5.1. Neurostimulation Devices Market: Application Movement Analysis
  • 5.2. Neurostimulation Devices for Pain Management Market
    • 5.2.1. Neurostimulation devices for pain management market, 2013-2024(USD Million)
  • 5.3. Neurostimulation Devices for Epilepsy Market
    • 5.3.1. Neurostimulation devices for epilepsy market, 2013-2024(USD Million)
  • 5.4. Neurostimulation Devices for Essential Tremor Market
    • 5.4.1. Neurostimulation devices for essential tremor market, 2013-2024(USD Million)
  • 5.5. Neurostimulation Devices for Urinary and Fecal Incontinence Market
    • 5.5.1. Neurostimulation devices for urinary and fecal incontinence market, 2013-2024(USD Million)
  • 5.6. Neurostimulation Devices for Depression Market
    • 5.6.1. Neurostimulation devices for depression market, 2013-2024(USD Million)
  • 5.7. Neurostimulation Devices for Dystonia Market
    • 5.7.1. Neurostimulation devices for dystonia market, 2013-2024(USD Million)
  • 5.8. Neurostimulation Devices for Gastroparesis Market
    • 5.8.1. Neurostimulation devices for gastroparesis market, 2013-2024(USD Million)
  • 5.9. Neurostimulation Devices for Parkinson's Disease Market
    • 5.9.1. Neurostimulation devices for Parkinson's disease market, 2013-2024(USD Million)
  • 5.10. Neurostimulation Devices for Other Diseases Market
    • 5.10.1. Neurostimulation devices for other diseases market, 2013-2024(USD Million)

Chapter 6: Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application

  • 6.1. Neurostimulation Devices Market Share by Region, 2016 & 2024
    • 6.1.1. North America
    • 6.1.2. North America neurostimulation devices market, by country, 2013-2024(USD Million)
    • 6.1.3. North America neurostimulation devices market, by country, 2013-2024('000 Units)
    • 6.1.4. North America neurostimulation devices market, by product, 2013-2024(USD Million)
    • 6.1.5. North America neurostimulation devices market, by product, 2013-2024('000 Units)
    • 6.1.6. North America neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.1.6.1. US
      • 6.1.6.2. US neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.1.6.3. US neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.1.6.4. US neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.1.6.5. Canada
      • 6.1.6.6. Canada neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.1.6.7. Canada neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.1.6.8. Canada neurostimulation devices market, by application, 2013-2024(USD Million)
    • 6.1.7. Europe
    • 6.1.8. Europe neurostimulation devices market, by country, 2013-2024(USD Million)
    • 6.1.9. Europe neurostimulation devices market, by country, 2013-2024('000 Units)
    • 6.1.10. Europe neurostimulation devices market, by product, 2013-2024(USD Million)
    • 6.1.11. Europe neurostimulation devices market, by product, 2013-2024('000 Units)
    • 6.1.12. Europe neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.1.12.1. Germany
      • 6.1.12.2. Germany neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.1.12.3. Germany neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.1.12.4. Germany neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.1.12.5. U.K.
      • 6.1.12.6. UK neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.1.12.7. UK neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.1.12.8. UK neurostimulation devices market, by application, 2013-2024(USD Million)
  • 6.2. Asia Pacific
    • 6.2.1. Asia Pacific neurostimulation devices market, by country, 2013-2024(USD Million)
    • 6.2.2. Asia Pacific neurostimulation devices market, by country, 2013-2024('000 Units)
    • 6.2.3. Asia Pacific neurostimulation devices market, by product, 2013-2024(USD Million)
    • 6.2.4. Asia Pacific neurostimulation devices market, by product, 2013-2024('000 Units)
    • 6.2.5. Asia Pacific neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.2.5.1. China
      • 6.2.5.2. China neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.2.5.3. China neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.2.5.4. China neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.2.5.5. Japan
      • 6.2.5.6. Japan neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.2.5.7. Japan neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.2.5.8. Japan neurostimulation devices market, by application, 2013-2024(USD Million)
  • 6.3. Latin America
    • 6.3.1. Latin America neurostimulation devices market, by country, 2013-2024(USD Million)
    • 6.3.2. Latin America neurostimulation devices market, by country, 2013-2024('000 Units)
    • 6.3.3. Latin America neurostimulation devices market, by product, 2013-2024(USD Million)
    • 6.3.4. Latin America neurostimulation devices market, by product, 2013-2024('000 Units)
    • 6.3.5. Latin America neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.3.5.1. Brazil
      • 6.3.5.2. Brazil neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.3.5.3. Brazil neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.3.5.4. Brazil neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.3.5.5. Mexico
      • 6.3.5.6. Mexico neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.3.5.7. Mexico neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.3.5.8. Mexico neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.3.5.9. Argentina
      • 6.3.5.10. Argentina neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.3.5.11. Argentina neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.3.5.12. Argentina neurostimulation devices market, by application, 2013-2024(USD Million)
    • 6.3.6. MEA
    • 6.3.7. MEA neurostimulation devices market, by country, 2013-2024(USD Million)
    • 6.3.8. MEA neurostimulation devices market, by country, 2013-2024('000 Units)
    • 6.3.9. MEA neurostimulation devices market, by product, 2013-2024(USD Million)
    • 6.3.10. MEA neurostimulation devices market, by product, 2013-2024('000 Units)
    • 6.3.11. MEA neurostimulation devices market, by application, 2013-2024(USD Million)
      • 6.3.11.1. South Africa
      • 6.3.11.2. South Africa neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.3.11.3. South Africa neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.3.11.4. South Africa neurostimulation devices market, by Application, 2013-2024(USD Million)
      • 6.3.11.5. Saudi Arabia
      • 6.3.11.6. Saudi Arabia neurostimulation devices market, by product, 2013-2024(USD Million)
      • 6.3.11.7. Saudi Arabia neurostimulation devices market, by product, 2013-2024('000 Units)
      • 6.3.11.8. Saudi Arabia neurostimulation devices market, by application, 2013-2024(USD Million)

Chapter 7: Competitive Landscape

  • 7.1. Company Profiles
    • 7.2.1. Company overview
    • 7.2.2. Financial performance
    • 7.2.3. Product benchmarking
    • 7.2.4. Strategic initiatives
  • 7.2. Medtronic
    • 7.2.1. Company overview
    • 7.2.2. Financial performance
    • 7.2.3. Product benchmarking
    • 7.2.4. Strategic initiatives
  • 7.3. St. Jude Medical
    • 7.3.1. Company overview
    • 7.3.2. Financial performance
    • 7.3.3. Product benchmarking
    • 7.3.4. Strategic initiatives
  • 7.4. Boston Scientific Corporation
    • 7.4.1. Company overview
    • 7.4.2. Financial performance
    • 7.4.3. Product benchmarking
    • 7.4.4. Strategic initiatives
  • 7.5. Cyberonics
    • 7.5.1. Company overview
    • 7.5.2. Financial performance
    • 7.5.3. Product benchmarking
    • 7.5.4. Strategic initiatives
  • 7.6. Nevro Corporation
    • 7.6.1. Company overview
    • 7.6.2. Financial performance
    • 7.6.3. Product benchmarking
    • 7.6.4. Strategic initiatives
  • 7.7. Neuronetics, Inc.
    • 7.7.1. Company overview
    • 7.7.2. Financial performance
    • 7.7.3. Product benchmarking
    • 7.7.4. Strategic initiatives
  • 7.8. Uroplasty, Inc.
    • 7.8.1. Company overview
    • 7.8.2. Financial performance
    • 7.8.3. Product benchmarking
    • 7.8.4. Strategic initiatives
  • 7.9. Codman & Shurtleff, Inc.
    • 7.9.1. Company overview
    • 7.9.2. Financial performance
    • 7.9.3. Product benchmarking
    • 7.9.4. Strategic initiatives
  • 7.10. IntraPace, Inc.
    • 7.10.1. Company overview
    • 7.10.2. Financial performance
    • 7.10.3. Product benchmarking
    • 7.10.4. Strategic initiatives

List of Tables

  • TABLE 1: Key spinal cord stimulators and their product approval status
  • TABLE 2: Key deep brain stimulators and their product approval status
  • TABLE 3: Key sacral nerve stimulators and their product approval status
  • TABLE 4: Key vagus nerve stimulators and their product approval status
  • TABLE 5: Global neurostimulation devices market, by geography, 2013 - 2024 (USD Million)
  • TABLE 6: Global neurostimulation devices market, by geography, 2013 - 2024 ('000 Units)
  • TABLE 7: North America neurostimulation devices market, by country, 2013 - 2024 (USD Million)
  • TABLE 8: North America neurostimulation devices market, by country, 2013 - 2024 ('000 Units)
  • TABLE 9: North America neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 10: North America neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 11: North America neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 12: US Neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 13: US Neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 14: US neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 15: Canada neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 16: Canada neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 17: Canada neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 18: Europe neurostimulation devices market, by country, 2013 - 2024 ('000 Units)
  • TABLE 19: Europe neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 20: Europe neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 21: Europe neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 22: Germany neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 23: Germany neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 24: Germany neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 25: UK neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 26: UK neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 27: UK neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 28: Asia Pacific neurostimulation devices market, by country, 2013 - 2024 (USD Million)
  • TABLE 29: Asia Pacific neurostimulation devices market, by country, 2013 - 2024 ('000 Units)
  • TABLE 30: Asia Pacific neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 31: Asia Pacific neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 32: Asia Pacific devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 33: China neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 34: China neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 35: China neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 36: Japan neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 37: Japan neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 38: Japan neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 39: Latin America neurostimulation devices market, by country, 2013 - 2024 (USD Million)
  • TABLE 40: Latin America neurostimulation devices market, by country, 2013 - 2024 ('000 Units)
  • TABLE 41: Latin America neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 42: Latin America neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 43: Latin America neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 44: Brazil neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 45: Brazil neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 46: Brazil neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 47: Mexico neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 48: Mexico neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 49: Mexico neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 50: Argentina neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 51: Argentina neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 52: Argentina neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 53: MEA neurostimulation devices market, by country, 2013 - 2024 (USD Million)
  • TABLE 54: MEA neurostimulation devices market, by country, 2013 - 2024 ('000 Units)
  • TABLE 55: MEA neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 56: MEA neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 57: MEA devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 58: South Africa neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 59: South Africa neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 60: South Africa neurostimulation devices market, by application, 2013 - 2024 (USD Million)
  • TABLE 61: Saudi Arabia neurostimulation devices market, by product, 2013 - 2024 (USD Million)
  • TABLE 62: Saudi Arabia neurostimulation devices market, by product, 2013 - 2024 ('000 Units)
  • TABLE 63: Saudi Arabia neurostimulation devices market, by application, 2013 - 2024 (USD Million)

List of Figures

  • FIG. 1: Market research process
  • FIG. 2: Information procurement
  • FIG. 3: Primary research pattern
  • FIG. 4: Market research approaches
  • FIG. 5: Value-chain-based sizing & forecasting
  • FIG. 6: QFD modeling for market share assessment
  • FIG. 7: Market trends & outlook
  • FIG. 8: Market segmentation & scope
  • FIG. 9: Market driver relevance analysis (Current & future impact)
  • FIG. 10: Global percentage of population, by age group, 2000 and 2050
  • FIG. 11: Neurostimulation devices market dynamics
  • FIG. 12: Key opportunities prioritized
  • FIG. 13: Neurostimulation devices market - Porter's analysis
  • FIG. 14: Neurostimulation devices market - PESTEL analysis
  • FIG. 15: Neurostimulation devices market: Company Market Share Analysis, 2015
  • FIG. 16: Neurostimulation devices market: Product movement analysis
  • FIG. 17: Spinal cord stimulators market, 2013 - 2024 (USD Million)
  • FIG. 18: Spinal cord stimulators market, 2013 - 2024 ('000 Units)
  • FIG. 19: Deep brain stimulators market, 2013 - 2024 (USD Million)
  • FIG. 20: Deep brain stimulators market, 2013 - 2024 ('000 Units)
  • FIG. 21: Sacral nerve stimulators market, 2013 - 2024 (USD Million)
  • FIG. 22: Sacral nerve stimulators market, 2013 - 2024 ('000 Units)
  • FIG. 23: Vagus nerve stimulators market, 2013 - 2024 (USD Million)
  • FIG. 24: Vagus nerve stimulators market, 2013 - 2024 ('000 Units)
  • FIG. 25: Gastric electric stimulators market, 2013 - 2024 (USD Million)
  • FIG. 26: Gastric electric stimulators market, 2013 - 2024 ('000 Units)
  • FIG. 27: Neurostimulation devices market: Product movement analysis
  • FIG. 28: Neurostimulation devices for pain management market, 2013 - 2024 (USD Million)
  • FIG. 29: Neurostimulation devices for epilepsy market, 2013 - 2024 (USD Million)
  • FIG. 30: Neurostimulation devices for essential tremor market, 2013 - 2024 (USD Million)
  • FIG. 31: Neurostimulation devices for urinary and fecal incontinence market, 2013 - 2024 (USD Million)
  • FIG. 32: Neurostimulation devices for depression market, 2013 - 2024 (USD Million)
  • FIG. 33: Neurostimulation devices for dystonia market, 2013 - 2024 (USD Million)
  • FIG. 34: Neurostimulation devices for gastroparesis market, 2013 - 2024 (USD Million)
  • FIG. 35: Neurostimulation devices for Parkinson's disease market, 2013 - 2024 (USD Million)
  • FIG. 36: Neurostimulation devices for other diseases market, 2013 - 2024 (USD Million)
  • FIG. 37: Neurostimulation devices revenue share by geography, 2016 & 2024
  • FIG. 38: Europe neurostimulation devices market, by country, 2013 - 2024 (USD Million)
Back to Top